Cytokeratin-18 was well studied as a single serological test for the diagnosis of NASH with the potential for screening for NASH; however, its sensitivity and specificity to predict steatohepatitis was not satisfactory [22]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.